Back to Search
ROBERT KANTOR, M.D.
M.D.
Dermatology Physician
NPI: 1508397886IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
25MA11525200(NJ)
CMS Specialties
PrimaryDERMATOLOGY
Education
OTHER
Class of 2017
Research & Publications (20)
Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.
PMID 19569972·Clin Infect Dis·2009
8-other
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.
PMID 19522657·Clin Infect Dis·2009
8-other
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
PMID 19490976·J Virol Methods·2009
4-observational
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.
PMID 19490972·J Virol Methods·2009
8-other
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.
PMID 19295330·J Acquir Immune Defic Syndr·2009
8-other
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
PMID 19266092·PLoS One·2009
6-review
Bayesian network analyses of resistance pathways against efavirenz and nevirapine.
PMID 18832874·AIDS·2008
4-observational
HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.
PMID 19000027·AIDS Res Hum Retroviruses·2008
8-other
Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.
PMID 17725424·AIDS Res Hum Retroviruses·2007
8-other
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.
PMID 17127103·Infect Genet Evol·2007
8-other
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.
PMID 16514293·AIDS·2006
4-observational
Impact of HIV-1 pol diversity on drug resistance and its clinical implications.
PMID 17075337·Curr Opin Infect Dis·2006
6-review
Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance.
PMID 17021157·Bioinformatics·2006
8-other
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.
PMID 16436728·Antimicrob Agents Chemother·2006
8-other
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
PMID 15943572·AIDS Res Hum Retroviruses·2005
8-other
The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.
PMID 16369376·MedGenMed·2005
8-other
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.
PMID 16136470·J Infect Dis·2005
3-trial
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
PMID 15839752·PLoS Med·2005
8-other
K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1.
PMID 15356825·Clin Infect Dis·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1255 BROAD ST
CLIFTON, NJ 07013 - Phone
- (973) 685-5735
Quick Facts
- NPI
- 1508397886
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile